Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04113044 · ClinicalTrials.gov registry record
Go Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS®
A clinical trial of Hip Fractures and Tibial Fractures, sponsored by AO Innovation Translation Center.
- Active
- Registry status
- 1,500
- Enrollment target
- 15
- Study locations
NCT04113044: Active study of Hip Fractures and Tibial Fractures, sponsored by AO Innovation Translation Center.
NCT04113044 is a study of Hip Fractures and Tibial Fractures that is active but no longer recruiting, run by AO Innovation Translation Center. The registered enrollment target is 1,500 participants, above the 521-participant average among 15 other Hip Fractures trials with a reported enrollment target (188% higher). The trial reports 15 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04113044, a study of Hip Fractures and Tibial Fractures, is active but no longer recruiting, sponsored by AO Innovation Translation Center.
- ACTIVE NOT RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 15
- Study locations
Study Summary
Prospective data will be collected in approximately 3500 patients (700 per 5 injury groups). Patients will be followed up according to the standard (routine) for up to 1 year after the treatment. Data collection will include underlying disease, treatment details, patient reported outcomes (PROs), anticipated or procedure-related adverse events (i.e. complications), and radiological outcomes.
Primary Outcome
* Radiographic measurements o Healing (Radiographic Union Score in Tibia Fractures \[RUST\]/ Radiographic Union Score in Hip Fractures \[RUSH\]) * Patient related outcomes * Patient Reported Outcome Measurement Information System (PROMIS): Physical Function (PF) short form Custom AO14 Pain Interference * Hip Disability and Osteoarthritis Outcome Score (HOOS-12) (assessing short- and long-term symptoms and function in hip injuries; the lower score indicates higher symptoms) * Knee Injur
Conditions Studied
Interventions
- OTHER All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics.
Study Locations (15)
Other
- Univ.-Klinik für Orthopädie und Traumatologie - Innsbruck
- Fundación Santa Fe de Bogotá - Bogotá
- Centrum für Muskuloskeletale Chirurgie (CMSC) Charite - Universitätsmedizin Berlin - Berlin
- University Hospital Freiburg - Freiburg im Breisgau
- Saarland University Hospital Department of Trauma, Hand and Reconstructive Surgery - Homburg
- Institut für Biomechanik Berufsgenossenschaftliche Unfallklinik Murnau - Murnau am Staffelsee
- Abteilung für Unfall- und Wiederherstellungschirurgie BG Klinik Tübingen - Tübingen
- University Medical Center Groningen - Groningen
- Isala Clinics - Zwolle
- Barts Health NHS Trust - London
- Oxford University Hospitals NHS Foundation Trust - Oxford
California
- Cedars-Sinai Department of Orthopaedics - Los Angeles
Florida
- University of Miami, Jackson Memorial Hospital Ryder Trauma Center - Miami
Massachusetts
- Massachusetts General Hospital Harvard Orthopaedic Trauma Initiative - Boston
Texas
- The Value Institute / Department of Surgery and Peri-operative Care. Dell Medical School, University of Texas at Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2026-12-31 |
What the registry record for NCT04113044 still lists
NCT04113044 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, above the 521-participant average among 15 other Hip Fractures trials with a reported enrollment target (188% higher).
The record links to 5 conditions, with Hip Fractures appearing as the primary indexed condition, and to 1 intervention - of which All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics. is the first listed.
NCT04113044 lists 15 locations in 5 states (Other, California, Florida).
Frequently Asked Questions
What is clinical trial NCT04113044 about?
NCT04113044 is a clinical study titled "Go Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS®". Prospective data will be collected in approximately 3500 patients (700 per 5 injury groups). Patients will be followed up according to the standard (routine) for up to 1 year after the treatment. Data collection will include underlying disease, treatment details, patient reported outcomes (PROs), ...
What is the current status of trial NCT04113044?
This trial is currently active not recruiting. The enrollment target is 1,500 participants. The study started on 2021-02-01. Estimated completion is 2026-12-31.
What conditions does trial NCT04113044 study?
This clinical trial studies the following conditions: Hip Fractures, Tibial Fractures, Ankle Fractures, Distal Radius Fracture, Humeral Fracture, Proximal.
What interventions are being tested in trial NCT04113044?
The interventions under investigation include: All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics. (OTHER).
Who is sponsoring clinical trial NCT04113044?
This trial is sponsored by AO Innovation Translation Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04113044 being conducted?
This trial has 15 study locations across California, Florida, Massachusetts, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04113044's enrollment target sits among peer trials
1,500 3rd of 15 higher than 13 of 15 other Hip Fractures trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hip Fractures trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
RECRUITING · NA
-
Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)
RECRUITING · NA
-
Cervical Myelopathy in Hip Fracture Patients
RECRUITING · NA
-
Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture
RECRUITING · Phase 4
-
PENG vs Femoral Block for Hip Fracture Analgesia
RECRUITING · NA
-
MDR - PMCF Study for Taperloc Complete Stems
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI